Chris currently helps lead healthcare investing at Laurion Capital Management, where he drives investment in public and private healthcare companies. Prior to joining Laurion in 2020, Chris was an Investment Analyst specializing in therapeutics at Mangrove Partners. Before he was an investor, Chris worked at Goldman Sachs as a biopharma Equity Research Analyst and before that as a biopharma Equity Research Associate at Canaccord Genuity. Chris earned a B.A. in Chemistry magna cum laude with a minor in Biochemistry from Carleton College and attended the University of Minnesota Medical School before transitioning into finance.